Village-based program to manage chronic heart conditions in Qujiang older adults

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The BOUQUET cohort is a prospective, village-based observational study enrolling about 30,000 residents aged 60 and older in Qujiang District with chronic cardiovascular diseases. Participants are offered a comprehensive management program including standardized pharmacologic treatment, lifestyle modification counseling, health education, structured long-term follow-up, and enhanced monitoring with 7-day ECG recordings. Data on clinical events, medication adherence, functional status, and quality of life will be collected and linked to routine care records. Outcomes will be followed for up to 10 years to observe rates of major cardiovascular events, hospitalizations, and mortality in a real-world community setting.

Why it matters

Who can join: the full rules

Inclusion Criteria

Age ≥60 years

Resident of Qujiang District

Diagnosed with chronic CVD (hypertension, coronary artery disease, heart failure, atrial fibrillation, or others)

Able and willing to provide informed consent

Exclusion Criteria

Severe cognitive impairment or inability to provide consent

Life expectancy \<1 year due to non-cardiovascular disease

Participation refusal

Where it's running

• Beijing Anzhen Hospital
  Beijing, Beijing Municipality, China Recruiting

Study contacts

• Study coordinator: Le Zhou, MD
• Email: 13840293506@163.com
• Phone: +8613840293506

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Reliability of Two-Stage Multiple-Repetition-Maximum Tests to Estimate 1-RM in People with Heart Disease and Risk Factors

  This study checks how well different formulas estimate the 1-RM from two submaximal tests in adults with heart disease or risk factors.

  Recruiting Technical University of Munich · München · NCT06796582

• Integrated care for older patients with atrial fibrillation

  This study is testing a new team-based care approach for older patients with atrial fibrillation and other health issues to see if it helps them manage their condition better than regular care.

  Recruiting at 50 sites Heart Care Foundation · Haskovo and 49 other locations · NCT06775028

• AI-powered ECG to help diagnose and predict outcomes in heart disease

  Researchers test an AI-enhanced ECG to help diagnose and predict outcomes for people with cardiovascular diseases.

  Recruiting Inha University Hospital · Incheon, Incheon · NCT07856472

• Pace-and-ablate strategy in atrial fibrillation: who benefits and long-term outcomes

  This study looks at adults with atrial fibrillation who underwent AV node ablation with permanent pacing to see who develops pacing-induced problems and how they do long-term.

  Recruiting at 5 sites Insel Gruppe AG, University Hospital Bern · Zabrze and 4 other locations · NCT07852221

• AI-based cardiac analysis using 12-lead and 1-lead ECG

  A clinician-facing pilot test to see if SmartECG-EF helps evaluate heart function using both 12-lead and single-lead ECGs in adults with heart conditions.

  Recruiting Inha University Hospital · Incheon, Incheon · NCT07844434

• Adapting and testing PEN-Plus in Zambian primary care

  Aiming to see if the PEN-Plus package can be adapted and used in two Zambian hospitals to better manage chronic diseases like heart disease, diabetes, hypertension, and sickle cell in primary care.

  Recruiting Centre for Infectious Disease Research in Zambia · Lusaka, Lusaka Province · NCT07753681

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.